NewsNestle to acquire remaining share of peanut allergy drug maker Aimmune for $2BadminSeptember 1, 2020 by adminSeptember 1, 2020011A company best known for making food products is acquiring the remainder of a biotech firm that won Food and Drug Administration approval for a...
NewsFive VCs share how the pandemic has changed investingadminJuly 19, 2020 by adminJuly 19, 2020010Despite the constant drumbeat of new Covid-19 cases, deals are getting done. In the first half of 2020, digital health companies raised record amounts of...
